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Methods Human coronary artery endothelial cells (HCAEC)
isolated from three different donors were cultured and stimu-
lated with pro-inflammatory cytokines TNF-a and IL-1b
(10 ng/ml each, for 48 hours), followed by incubation with
native human AcLDL cholesterol at multiple concentrations
(10–200 ug/ml) for 6 hours. Cell lysates and culture superna-
tants were collected and analysed for IL-1b using ELISA. Cell
viability was also measured.
Results AcLDL induced the release of IL-1b from stimulated
HCAECs in a dose dependent manner with maximum release
(155.4 pg/ml, n=3) at concentration of 50 ug/ml. This was 4
fold greater than that released by cytokine-stimulated
(38.49 pg/ml, n=3) and 3 fold greater than that released by
neutrophil elastase (49.45 pg/ml, n=3). This release was not
caused by toxicity of the AcLDL: cell viability was confirmed
by lactate dehydrogenase cell viability assay.
Conclusion AcLDL is capable of eliciting IL-1b release in acti-
vated HCAECs, without causing toxicity.
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Introduction Myocardial infarction (MI) is a prominent cause
of morbidity and mortality globally. While reperfusion via pri-
mary percutaneous coronary intervention is the gold-standard
therapy, it can lead to the phenomenon ischemia-reperfusion
injury (IRI), characterised by progressive remodelling and heart
failure. Little is understood regarding to the mechanisms driv-
ing IRI, however, increased oxidative stress is known to play a
role. Our previous studies demonstrate that during ageing
increased oxidative stress drives telomere associated DNA dam-
age foci (TAF) induced cardiomyocyte senescence, which is
directly associated with a hypertrophic phenotype. Furthermore
senescent cardiomyocytes express a pro-fibrotic profile; in par-
ticular an up-regulation of TGF-b expression. We now
hypothesise that cardiomyocyte senescence contributes to
remodelling subsequent to MI and IRI via similar mechanisms,
and as such represents a potential therapeutic target.
Methods Young three month old mice underwent 60 min sur-
gical ligation of the left anterior descending coronary artery
to mimic MI followed by reperfusion. Histological analysis at
numerous time points post-MI for several senescence markers
was performed.
Results and conclusions In support of our hypothesis, we have
observed that within the surviving myocardium, proximal to
the infarct region, cardiomyocytes acquire a senescent-like phe-
notype. This is demonstrated by an increase in senescence
markers including SA-b-Gal, p21 and p16, in addition to an
accumulation of TAF. As well as this we verified that mice
displayed classical pathophysiological aspects related to MI.
Using in vitro studies and transgenic mouse models we aim to
better understand the biology underlying cardiomyocyte senes-
cence, and to establish the mechanisms underlying senescence
contribution to remodelling. Furthermore we aim to ascertain
if modulation or clearance of cardiomyocyte senescence pro-
motes regeneration and improves outcome following IRI.
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Background Identification of in vivo thrombus formation has the
potential to assist in the diagnosis and management of acute coro-
nary atherothrombosis. ENC2015 is a 13-amino acid fluorescent
peptide analogue of 2-antiplasmin which binds to newly formed
thrombus. Our aim was to assess the binding of both optical (Cy5)
and PET (18F) labelled ENC2015 acute human thrombus forma-
tion in a translational model of deep arterial injury.
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